Search research articles
Contact Us
Filters
Showing results (1-10 of 66) with videos related to
Page
of 7
Sort By:
European Urology
|
December 11, 2012
Words of wisdom. Re: Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors
Emma H Allott, Stephen J Freedland
Endocrine-Related Cancer
|
September 17, 2015
Obesity and cancer: mechanistic insights from transdisciplinary studies
Emma H Allott, Stephen D Hursting
Cancers
|
November 27, 2021
Characterizing and Exploiting Tumor Microenvironments to Optimize Treatment Outcomes
Emma H Allott, Kellie Dean, Tracy Robson, et al.
BJU International
|
April 24, 2012
C-reactive protein as a prognostic marker FOR mCRPC
Michael R Abern, Emma H Allott, Stephen J Freedland
European Urology
|
December 11, 2012
The relationship between nutrition and prostate cancer: is more always better?
Elizabeth M Masko, Emma H Allott, Stephen J Freedland
Prostate Cancer and Prostatic Diseases
|
March 30, 2021
In search of the optimal setting for statin trials in prostate cancer: the power of population-based studies
Emma H Allott, Emma L Craig, Konrad H Stopsack
European Urology
|
September 5, 2018
Statin Therapy to Improve Prostate Cancer Outcomes: Who, When, and for How Long?
Emma H Allott, Michael R Freeman, Stephen J Freedland
European Urology
|
December 11, 2012
Obesity and prostate cancer: weighing the evidence
Emma H Allott, Elizabeth M Masko, Stephen J Freedland
European Urology
|
April 24, 2013
Words of wisdom. Re: Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1
Keith R Solomon, Emma H Allott, Michael R Freeman, et al.
Frontiers in Oncology
|
August 23, 2013
Mechanistic targets and phytochemical strategies for breaking the obesity-cancer link
Nikki A Ford, Laura M Lashinger, Emma H Allott, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 66) with videos related to
Sort By:
Page
of 7
European Urology
|
December 11, 2012
Words of wisdom. Re: Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors
Emma H Allott, Stephen J Freedland
Endocrine-Related Cancer
|
September 17, 2015
Obesity and cancer: mechanistic insights from transdisciplinary studies
Emma H Allott, Stephen D Hursting
Cancers
|
November 27, 2021
Characterizing and Exploiting Tumor Microenvironments to Optimize Treatment Outcomes
Emma H Allott, Kellie Dean, Tracy Robson, et al.
BJU International
|
April 24, 2012
C-reactive protein as a prognostic marker FOR mCRPC
Michael R Abern, Emma H Allott, Stephen J Freedland
European Urology
|
December 11, 2012
The relationship between nutrition and prostate cancer: is more always better?
Elizabeth M Masko, Emma H Allott, Stephen J Freedland
Prostate Cancer and Prostatic Diseases
|
March 30, 2021
In search of the optimal setting for statin trials in prostate cancer: the power of population-based studies
Emma H Allott, Emma L Craig, Konrad H Stopsack
European Urology
|
September 5, 2018
Statin Therapy to Improve Prostate Cancer Outcomes: Who, When, and for How Long?
Emma H Allott, Michael R Freeman, Stephen J Freedland
European Urology
|
December 11, 2012
Obesity and prostate cancer: weighing the evidence
Emma H Allott, Elizabeth M Masko, Stephen J Freedland
European Urology
|
April 24, 2013
Words of wisdom. Re: Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1
Keith R Solomon, Emma H Allott, Michael R Freeman, et al.
Frontiers in Oncology
|
August 23, 2013
Mechanistic targets and phytochemical strategies for breaking the obesity-cancer link
Nikki A Ford, Laura M Lashinger, Emma H Allott, et al.
Page
of 7